Stock listing
OTC:BTHE Boston Therapeutics Inc Stock
Follow Boston Therapeutics Inc into a list and get an email when it puts out news.
Delisted OTC:BTHE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- OTC:BTHE
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Boston Therapeutics Inc on 6ix
- Decks
- 4 decks · latest Nov 5, 2021
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2021) | Investor deck | 21 slides | Nov 5, 2021 |
| Investor Presentation (June 2018) | Investor deck | 18 slides | Jun 1, 2018 |
| Investor Presentation (October 2012) | Investor deck | 32 slides | Oct 10, 2012 |
| Investor Presentation (April 2012) | Investor deck | 15 slides | Apr 27, 2012 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Dale H. Conaway Other companies: Bioxytran, Inc. (Director · Since at least Jul 1, 2020); Galectin Therapeutics Inc. (Director · Mar 9, 2006 – Feb 8, 2009 · Past) | Director · Apr 4, 2014 – May 15, 2015 · Past |
| Anthony Don Squeglia Other companies: Galectin Therapeutics Inc. (Chief Financial Officer · Oct 1, 2007 – Feb 2, 2010 · Past) | Chief Financial Officer · Dec 3, 2013 – Mar 10, 2015 · Past |
| Jonathan B Rome | Chief Operating Officer (3) · Jan 29, 2014 – Jan 29, 2014 · Past |
| Kenneth A Tassey Jr | CEO, President, Director · Mar 23, 2012 – Feb 12, 2014 · Past |
| Loraine Upham | Chief Operating Officer · Feb 12, 2018 – Feb 12, 2018 · Past |
| Rom E Eliaz | Director · Apr 4, 2014 – Apr 4, 2014 · Past |
Log in to ask 6ix AI your own questions about Boston Therapeutics Inc.